# Radiation Therapy or Temozolomide in Treating Patients With Gliomas

> **NCT00182819** · PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 709 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** temozolomide
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00182819
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2013-08
- **Final completion:** 2014-05
- **Target enrollment:** 709 (ACTUAL)
- **Last updated:** 2016-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182819, "Radiation Therapy or Temozolomide in Treating Patients With Gliomas". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00182819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*